Researcher.Life Logo

Clinical and Experimental Rheumatology : Impact Factor & More

eISSN: 1593-098XpISSN: 0392-856X

Key Metrics

CiteScore
6.1
H-Index
104
Impact Factor
< 5
SJR
Q2Immunology
SNIP
1.56
Recommended pre-submission checks
Powered by Paperpal by Editage

Clinical and Experimental Rheumatology Journal Specifications

Overview
Publisher CLINICAL & EXPER RHEUMATOLOGY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1983
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical and Experimental Rheumatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Experimental Rheumatology

Sex differences in idiopathic inflammatory myopathies: insights from a large multicentre observational study.
  • 18 May 2026
  • Clinical and experimental rheumatology
Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus.
  • 18 May 2026
  • Clinical and experimental rheumatology
Fibromyalgia and metabolic syndrome: prevalence, potential shared pathophysiological mechanisms and non-pharmacological treatment strategies.
  • 14 May 2026
  • Clinical and experimental rheumatology
Reply to the comment on: IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review.
  • 13 May 2026
  • Clinical and experimental rheumatology
Comment on: IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review.
  • 13 May 2026
  • Clinical and experimental rheumatology
Sequential treatment strategies following methotrexate inadequate response in rheumatoid arthritis: a real-world retrospective cohort study.
  • 13 May 2026
  • Clinical and experimental rheumatology
Sex differences in idiopathic inflammatory myopathies: insights from a large multicentre observational study.
  • 18 May 2026
  • Clinical and experimental rheumatology
Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus.
  • 18 May 2026
  • Clinical and experimental rheumatology
Fibromyalgia and metabolic syndrome: prevalence, potential shared pathophysiological mechanisms and non-pharmacological treatment strategies.
  • 14 May 2026
  • Clinical and experimental rheumatology
Reply to the comment on: IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review.
  • 13 May 2026
  • Clinical and experimental rheumatology
Comment on: IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review.
  • 13 May 2026
  • Clinical and experimental rheumatology
Sequential treatment strategies following methotrexate inadequate response in rheumatoid arthritis: a real-world retrospective cohort study.
  • 13 May 2026
  • Clinical and experimental rheumatology

FAQs on Clinical and Experimental Rheumatology